Nykode Therapeutics ASA VACBF Price Prediction & Forecast

Home

Stock

VACBF

Forecast

VACBF Stock Price Prediction

Nykode Therapeutics ASA

$0.38

At close: Mar 27, 16:00:00 GMT-4

$0.38

Post-market: Mar 27, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.38

Open

$0.31

Day's Range

$0.31 - $0.38

52 week range

$0.1557 - $0.38

Volume

10.0K

Avg.Volume

246

Dividend yield

EPS (TTM)

-0.03

Market Cap

$124.0M

What is NYKODE THERAPEUTICS ASA?

Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company is headquartered in Oslo, Oslo and currently employs 59 full-time employees. The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.



Features

AI Copilot for Stock & Crypto

Resources

Market

According to analyst forecasts, we anticipate notable price fluctuations for VACBF in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $0.4335. The lowest target is $0.15 and the highest is $0.7365. Empower your investment choices with our cutting-edge, data-driven analysis!

VACBF Stock Price Prediction Summary

Top Analyst Ratings for VACBF

Based on 9 analysts giving stock ratings to VACBF, updated on Sep 01, 2025

Sell

Strong buy

Buy

Hold

Sell

Strong sell

Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for VACBF. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: VACBF is a Sell candidate.

VACBF stock price ended at $0.38 on Tuesday, after rising 22.58%

On the latest trading day Feb 10, 2026, the stock price of VACBF rose by 22.58%, climbing from $0.38 to $0.38. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.38 and a high of $0.38. Notably, trading volume dropped by 4.3K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 4.3K shares were traded, equating to a market value of approximately $124.0M.

VACBF Technical Signals

Technical Signals Summary

Buy Signals 2

Neutral Signals 4

Sell Signals 1

Strong Sell

Sell

Neutral

Buy

Strong Buy

VACBF currently exhibits 2 buy signals and 1 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of 22.58% during this period. Overall, the technical indicators point to a Buy outlook for the mid-term.

Bullish/Bearish Signals for VACBF

Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for VACBF. These insights help you make informed investment decisions.

Follow-Up Questions

How do technical analysis indicators apply to VACBF?



According to technical analysis, Nykode Therapeutics ASA has an aggregate signal of Buy. Nykode Therapeutics ASA has 2 Buy signals, 4 Neutral Signals and 1 sell signals.

What are the Fibonacci retracement levels for VACBF?



The Fibonacci retracement level for Nykode Therapeutics ASA is between 78.6% and 100%

What is the RSI for Nykode Therapeutics ASA?



The RSI for Nykode Therapeutics ASA is currently 66.76, indicating a neutral condition

What is Nykode Therapeutics ASA price for the next 12 months?



Nykode Therapeutics ASA VACBF price for the next 12 months is estimated at $0.4335.

How high is Nykode Therapeutics ASA expected to go?



According to wall street analysts, Nykode Therapeutics ASA is expected to reach a high forecast of $0.7365.

Nykode Therapeutics ASA (VACBF) Stock Price Prediction

VACBF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NYKODE THERAPEUTICS ASA?

VACBF Stock Price Prediction Summary

Should I Buy VACBF ?

Top Analyst Ratings for VACBF

VACBF stock price ended at $0.38 on Tuesday, after rising 22.58%

VACBF Technical Signals

Technical Signals Summary

Bullish/Bearish Signals for VACBF

Follow-Up Questions

How do technical analysis indicators apply to VACBF?

What are the Fibonacci retracement levels for VACBF?

What is the RSI for Nykode Therapeutics ASA?

What is Nykode Therapeutics ASA price for the next 12 months?

How high is Nykode Therapeutics ASA expected to go?